首页|期刊导航|实用临床医药杂志|蠲浊通络方治疗脾虚湿阻型妇科肿瘤术后下肢淋巴水肿的临床疗效

蠲浊通络方治疗脾虚湿阻型妇科肿瘤术后下肢淋巴水肿的临床疗效OA

Clinical efficacy of Juanzhuo Tongluo Formula in treating lower limb lymphedema after gynecological tumor surgery in patients with spleen-deficiency and dampness-obstruction syndrome

中文摘要英文摘要

目的 观察蠲浊通络方治疗脾虚湿阻型妇科肿瘤术后下肢淋巴水肿(LLL)的临床疗效.方法 选取2024年1月—2025年7月南京中医药大学附属医院/江苏省中医院肿瘤内科收治的妇科肿瘤术后LLL患者为研究对象,采用随机数字表法分为观察组(50例,脱落1例)和对照组(50例,剔除1例).观察组予蠲浊通络汤联合综合消肿治疗(CDT),对照组予地奥司明联合CDT,疗程均为4周.比较2组治疗前后患侧下肢周径、生物电阻抗、细胞外水分、患肢节段水分、白细胞介素(IL)-6、IL-1 β、肿瘤坏死因子-α(TNF-α)、淋巴水肿生活质量问卷(LYMQOL)评分和中医证候评分,并于治疗结束后进行疗效评估.结果 观察组治疗总有效率为89.80%,高于对照组的65.31%,差异有统计学意义(P=0.004);绝对风险差为24.50%(95%CI:0.081 2~0.408 6),Cramer's V=0.293,为中等程度差异.治疗后,2组患者患侧下肢足背、外踝尖、髌骨上缘、髌骨上缘10 cm、髌骨下缘10 cm周径均较治疗前缩小,且观察组小于对照组,差异有统计学意义(P<0.05);足背周径变化组间差异效应量 Cohen's d=0.467(95%CI:0.066~0.868),外踝尖周径变化 Cohen's d=1.582(95%CI:1.129~2.036),髌骨上缘周径变化 Cohen'sd=2.538(95%CI:2.004~3.073),髌骨上缘 10 cm 周径变化 Cohen's d=1.861(95%CI:1.386~2.337),髌骨下缘10 cm周径变化Cohen's d=1.852(95%CI:1.377~2.326).治疗4周时,2组患者50 Hz生物电阻抗值较治疗前升高,且观察组高于对照组,差异有统计学意义(P<0.05);2组患者细胞外水分、患肢节段水分均较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05).治疗4周时,2组患者IL-6、IL-1 β、TNF-α水平均较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05).治疗4周时,2组患者LYMQOL中的"功能""外观""症状""情绪"维度评分均较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05);2组患者"总体生活质量"评分较治疗前升高,且观察组高于对照组,差异有统计学意义(P<0.05).治疗4周时,2组患者中医证候评分均较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05).结论 蠲浊通络方治疗脾虚湿阻型妇科肿瘤术后LLL疗效显著,可缩小患肢周径,减轻水肿程度,降低炎症细胞因子表达,提高患者生存质量.

Objective To observe the clinical efficacy of Juanzhuo Tongluo Formula in treating lower limb lymphedema(LLL)after gynecological tumor surgery in patients with spleen-deficiency and dampness-obstruction syndrome.Methods Patients with LLL after gynecological tumor surgery admitted to the Oncology Department of the Affiliated Hospital of Nanjing University of Chinese Med-icine,Jiangsu Provincial Hospital of Traditional Chinese Medicine from January 2024 to July 2025 were selected.They were randomly divided into observation group(50 cases,with 1 case dropped out)and control group(50 cases,with 1 case excluded)using a random number table method.The observation group received Juanzhuo Tongluo Formula combined with complex decongestive therapy(CDT),while the control group received diosmin combined with CDT.The treatment course was 4 weeks for both groups.The circumferences of the affected lower limb at different sites,bioelectrical impedance,extracellular water,segmental water of the affected limb,levels of interleukin(IL)-6,IL-1 β,tumor necrosis factor-α(TNF-α),Lymphedema Quality of Life Questionnaire(LYMQOL)scores,and traditional Chinese medicine(TCM)syndrome scores were compared between the two groups before and after treatment.The therapeutic efficacy was evaluated at the end of treatment.Results The total effective rate in the observation group was 89.80%,which was higher than that in the control group(65.31%),with a statistically significant difference(P=0.004).The abso-lute risk difference was 24.50%(95%CI:0.081 2 to 0.408 6),and Cramer's V was 0.293,indi-cating a moderate difference.After treatment,the circumferences of the dorsum of the foot,lateral malleolus tip,superior border of the patella,10 cm above the superior border of the patella,and 10 cm below the inferior border of the patella of the affected lower limb in both groups were smaller than those before treatment,and the circumferences in the observation group were smaller than those in the control group(P<0.05).The effect sizes(Cohen's d)for the changes in circumferences were as follows:dorsum of the foot,0.467(95%CI:0.066 to 0.868);lateral malleolus tip,1.582(95%CI:1.129 to 2.036);superior border of the patella,2.538(95%CI:2.004 to 3.073);10 cm above the superior border of the patella,1.861(95%CI:1.386 to 2.337);and 10 cm below the inferior border of the patella,1.852(95%CI:1.377 to 2.326).At week 4 of treatment,the 50 Hz bioelectrical impedance values in both groups were higher than those before treatment,and the val-ues in the observation group were higher than those in the control group,with statistically significant differences(P<0.05).The extracellular water and segmental water of the affected limb in both groups were lower than those before treatment,and the values in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).At week 4 of treatment,the levels of IL-6,IL-1 β,and TNF-α in both groups were lower than those before treat-ment,and the levels in the observation group were lower than those in the control group,with statis-tically significant differences(P<0.05).At week 4 of treatment,the scores of the"function""appearance""symptoms"and"mood"dimensions in the LYMQOL in both groups were lower than those before treatment,and the scores in the observation group were lower than those in the control group,with statistically significant differences(P<0.05).The"overall quality of life"scores in both groups were higher than those before treatment,and the scores in the observation group were higher than those in the control group,with statistically significant differences(P<0.05).At week 4 of treatment,the TCM syndrome scores in both groups were lower than those before treatment,and the scores in the observation group were lower than those in the control group,with statistically sig-nificant differences(P<0.05).Conclusion Juanzhuo Tongluo Formula has a significant thera-peutic effect on LLL after gynecological tumor surgery in patients with spleen-deficiency and damp-ness-obstruction syndrome.It can reduce the circumference of the affected limb,alleviate edema,decrease the expression of inflammatory cytokines,and improve the quality of life.

卢曼;钱军;侯庆梅;陈晶晶;王茜;聂多锐;胡玥

南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029||南京中医药大学第一临床医学院,江苏南京,210023南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029南京中医药大学附属医院/江苏省中医院肿瘤内科,江苏南京,210029

医药卫生

淋巴水肿妇科肿瘤术后并发症随机对照试验中药疗法脾虚湿气生活质量

lymphedemagynecological tumorpostoperative complicationsrandomized con-trolled trialtraditional Chinese medicine therapyspleen deficiencydampnessquality of life

《实用临床医药杂志》 2026 (8)

85-92,8

国家自然科学基金青年科学基金项目(82505345)国家中医优势专科项目(国中医药医[2024]90)江苏省研究生实践创新计划项目(SJCX25-0982)

10.7619/jcmp.20260199

评论